chr16-13920167-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_SupportingPM2
The NM_005236.3(ERCC4):āc.2T>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,604,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005236.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC4 | NM_005236.3 | c.2T>G | p.Met1? | start_lost | Exon 1 of 11 | ENST00000311895.8 | NP_005227.1 | |
ERCC4 | XM_011522424.4 | c.2T>G | p.Met1? | start_lost | Exon 1 of 12 | XP_011520726.1 | ||
LOC105371093 | XR_007064999.1 | n.82+6358A>C | intron_variant | Intron 1 of 2 | ||||
LOC105371093 | XR_007065000.1 | n.82+6358A>C | intron_variant | Intron 1 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000829 AC: 2AN: 241290Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131970
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1452596Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 723100
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74368
ClinVar
Submissions by phenotype
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Uncertain:1
This sequence change affects the initiator methionine of the ERCC4 mRNA. The next in-frame methionine is located at codon 12. This variant is present in population databases (rs778859873, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with ERCC4-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at